Hospital and medical care days in pancreatic cancer

Annals of Surgical Oncology

Volumn 19, Issue 8, 2012, Pages 2435-2442

  Boyd, Casey A ^a   Branch, Daniel W ^a   Sheffield, Kristin M ^a   Han, Yimei ^a   Kuo, Yong Fang ^a   Goodwin, James S ^a   Riall, Taylor S ^a  

^a University of Texas Medical Branch School of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER REGISTRY; CANCER SURGERY; CANCER SURVIVAL; CORRELATION ANALYSIS; FEMALE; HOSPITAL CARE; HUMAN; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; PANCREAS CANCER; PANCREAS RESECTION; SURVIVAL TIME; TERMINAL CARE;

ADENOCARCINOMA; AGED; COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; LENGTH OF STAY; MALE; NEOPLASM STAGING; PANCREATIC NEOPLASMS; PATIENT CARE TEAM; PATIENT-CENTERED CARE; PROGNOSIS; SEER PROGRAM; SURVIVAL RATE;

EID: 84864987972     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-012-2326-2     Document Type: Article

References (21)

1. A Jemal R Siegel J Xu E Ward 2010 Cancer statistics, 2010 CA Cancer J Clin. 60 1 24 10.3322/caac.20073
2. EE Zervos AS Rosemurgy O Al-Saif AJ Durkin 2004 Surgical management of early-stage pancreatic cancer Cancer Control. 11 23 31 14749620
3. Surveillance, Epidemiology, and End Results (SEER) Program. http://seer.cancer.gov/about/.
4. KY Bilimoria DJ Bentrem CY Ko AK Stewart DP Winchester MS Talamonti 2007 National failure to operate on early stage pancreatic cancer Ann Surg. 246 173 180 17667493 10.1097/SLA.0b013e3180691579
5. TS Riall JL Cameron KD Lillemoe, et al. 2006 Resected periampullary adenocarcinoma: 5-year survivors and their 6- to 10-year follow-up Surgery. 140 764 772 17084719 10.1016/j.surg.2006.04.006
6. TS Riall KM Sheffield YF Kuo CM Townsend Jr JS Goodwin 2011 Resection benefits older adults with locoregional pancreatic cancer despite greater short-term morbidity and mortality J Am Geriatr Soc. 59 647 654 21453378 10.1111/j.1532-5415.2011.03353.x
7. TE Ciuleanu AV Pavlovsky G Bodoky, et al. 2009 A randomised phase III trial of glufosfamide compared with best supportive care in metastatic pancreatic adenocarcinoma previously treated with gemcitabine Eur J Cancer. 45 1589 1596 19188061 10.1016/j.ejca.2008.12.022 1:CAS:528:DC%2BD1MXms1WmtLo%3D
8. D Cunningham I Chau DD Stocken, et al. 2009 Phase III randomized comparison of gemcitabine versus gemcitabine plus capecitabine in patients with advanced pancreatic cancer J Clin Oncol. 27 5513 5518 19858379 10.1200/JCO.2009.24.2446 1:CAS:528:DC%2BC3cXhtVWitrc%3D
9. TC Nguyen TA Sohn JL Cameron, et al. 2003 Standard vs. radical pancreaticoduodenectomy for periampullary adenocarcinoma: a prospective, randomized trial evaluating quality of life in pancreaticoduodenectomy survivors J Gastrointest Surg. 7 1 9 12559179 10.1016/S1091-255X(02)00187-7
10. SEER-Medicare. Medicare claims files. http://healthservices.cancer.gov/ seermedicare/medicare/claims.html.
11. KM Sheffield CA Boyd J Benarroch-Gampel YF Kuo CD Cooksley TS Riall 2011 End-of-life care in medicare beneficiaries dying with pancreatic cancer Cancer. 117 5003 5012 21495020 10.1002/cncr.26115
12. R Carter DD Stocken P Ghaneh, et al. 2009 Longitudinal quality of life data can provide insights on the impact of adjuvant treatment for pancreatic cancer-subset analysis of the ESPAC-1 data Int J Cancer. 124 2960 2965 19330830 10.1002/ijc.24270 1:CAS:528:DC%2BD1MXltlCgtLg%3D
13. P Heras K Kritikos A Hatzopoulos N Kritikos S Karagiannis D Mitsibounas 2009 Effect of combined treatment methods on quality of life in patients with pancreatic cancer Am J Ther. 16 316 318 19455022 10.1097/MJT.0b013e318195e33c
14. MJ Morak CJ Pek EJ Kompanje WC Hop G Kazemier CH van Eijck 2010 Quality of life after adjuvant intra-arterial chemotherapy and radiotherapy versus surgery alone in resectable pancreatic and periampullary cancer: a prospective randomized controlled study Cancer. 116 830 836 20029974 10.1002/cncr.24809 1:CAS:528:DC%2BC3cXivFajsr4%3D
15. JJ Huang CJ Yeo TA Sohn, et al. 2000 Quality of life and outcomes after pancreaticoduodenectomy Ann Surg. 231 890 898 10816633 10.1097/00000658- 200006000-00014 1:STN:280:DC%2BD3c3nslymtg%3D%3D
16. Nieveen van Dijkum EJ, Kuhlmann KF, Terwee CB, Obertop H, de Haes JC, Gouma DJ. Quality of life after curative or palliative surgical treatment of pancreatic and periampullary carcinoma. Br J Surg. 2005;92:471-7.
17. Adjuvant! Online. Decision making tools for health care professionals. http://adjuvantonline.com/index.jsp.
18. P Bao D Potter DP Eisenberg, et al. 2009 Validation of a prediction rule to maximize curative (R0) resection of early-stage pancreatic adenocarcinoma HPB (Oxford). 11 606 611 10.1111/j.1477-2574.2009.00110.x
19. DY Greenblatt KJ Kelly V Rajamanickam, et al. 2011 Preoperative factors predict perioperative morbidity and mortality after pancreaticoduodenectomy Ann Surg Oncol. 18 2126 2135 21336514 10.1245/s10434-011-1594-6
20. DS Greer V Mor JN Morris S Sherwood D Kidder H Birnbaum 1986 An alternative in terminal care: results of the National Hospice Study J Chronic Dis. 39 9 26 3511081 10.1016/0021-9681(86)90103-7 1:STN:280:DyaL287ht1eqtg%3D%3D
21. SR Connor B Pyenson K Fitch C Spence K Iwasaki 2007 Comparing hospice and nonhospice patient survival among patients who die within a three-year window J Pain Symptom Manage. 33 238 246 17349493 10.1016/j.jpainsymman.2006.10.010